Antibodies

19 May 2008 Schering-Plough Extends Antibody Alliance with MorphoSys
16 May 2008 ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting
15 May 2008 Lpath's iSONEP(TM) IND Application Gets Green Light From FDA
13 May 2008 Phase II Study of IMC-A12 for Advanced Liver Cancer Opens for Patient Enrollment
13 May 2008 Affimed validates antibody target for cancer metastasis
13 May 2008 Start of Phase II Clinical Study for Rabies Monoclonal Antibody Combination in the Philippines
13 May 2008 Active Biotech advances ANYARA into Phase III clinical trial
12 May 2008 Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
09 May 2008 Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis
08 May 2008 Bayer and Regeneron start additional Phase 3 Study for VEGF Trap-Eye in Wet Age-related Macular Degeneration
08 May 2008 Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
30 Apr 2008 Merck Serono and ZymoGenetics Initiate Atacicept Phase 2 Clinical Trial in Relapsing Multiple Sclerosis
29 Apr 2008 Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
29 Apr 2008 Genentech and Biogen Idec Announce Top-Line Results From Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus
28 Apr 2008 MorphoSys Announces Completion of First Dosing in Phase 1 Trial for MOR103 Program
28 Apr 2008 Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
28 Apr 2008 KaloBios Completes Patient Dosing in its U.S. Phase 1 Trial of Its Third Drug Candidate, KB003
28 Apr 2008 Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
24 Apr 2008 ESBATech's Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
24 Apr 2008 MorphoSys and the Leibniz-Institut für Molekulare Pharmakologie Sign Broad Research Partnership
24 Apr 2008 Arana and Kyowa Hakko to co-develop anti-cancer drug
24 Apr 2008 Micromet Enrolls First Patient in Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
23 Apr 2008 ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer
23 Apr 2008 Single, Intramuscular (IM) Dose, Protects up to 75 Percent in Primate Study
23 Apr 2008 CimziaA(R) Approved in the US for the Treatment of Moderate to Severe Crohn's Disease

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top